Drug intelligence / Profile preview

FucoVital

Development stage
Preclinical
Lead developer
Algatech
Modality
Small Molecules
Administration
Oral
01

Overview

FucoVital is a patented, all‑natural fucoxanthin‑rich oleoresin dietary ingredient derived from the microalga Phaeodactylum tricornutum and standardized to about 3% fucoxanthin along with omega‑3 fatty acids such as EPA and other beneficial lipids.[2][8][10][1] Developed by Algatech (Algatechnologies, part of Solabia), it is positioned for liver health and metabolic support, with preclinical and early clinical data indicating reductions in blood triglyceride levels and inhibition of fat accumulation in liver cells, effects that are partly attributed to inhibition of pancreatic lipase and modulation of lipid metabolism relevant to metabolic syndrome and non‑alcoholic fatty liver disease.[4][10][16][19] FucoVital is the first microalgae‑derived fucoxanthin composition to receive FDA New Dietary Ingredient Notification for use in dietary supplements, is cultivated in a closed, sustainable photobioreactor system, and is marketed as a premium nutraceutical ingredient for incorporation into oral formulations such as capsules for liver and cardiometabolic health applications.[2][5][8][1][13]

Brand names
FucoVital
Other names
FucoVital fucoxanthin oleoresinFucoVital fucoxanthin-rich supplement
02

Targets

PNLIP (Pancreatic triacylglycerol lipase)

Beyond the preview

Go deeper on FucoVital.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FucoVital.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call